Supporting Legislation for Independent Post-Marketing (Phase IV) Comparative Evaluation of Pharmaceuticals

  • 20031

You must be a logged-in APHA member to view this archived policy statement.

Already a member? Please log in now. Not a member? Find out how to join us.

SHARE